Track topics on Twitter Track topics that are important to you
Aptalis Pharma is a privately held, leading specialty pharmaceutical company providing innovative, effective therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. Aptalis has manufacturing and commercial operations in the United States, the European Union and Canada, and its products include ZENPEP®, CANASA®, CARAFATE®, PYLERA®, RECTIV®, VIOKACE™, ULTRESA™ LACTEOL®, DELURSAN®, PANZYTRAT®, and SALOFALK®. Aptalis also formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, and taste-masking/orally disintegrating tablet (ODT) formulations.
22 Inverness Center Parkway
Phone: (800) 472-2634
Fax: (205) 991-8426
Anonymous sources tell Reuters TPG Capital's price tag deterred some potential bidders for Aptalis Pharma.
In this episode of PharmaTelevision News Review, filmed at BIO 2011, Fintan Walton talks to John Fraher, President of Aptalis.
In this episode of PharmaTelevision News Review, filmed at #BIO 2012 in Boston, Fintan Walton talks to John Fraher, President of Aptalis
04/26/12 Bioresearch Online Newsletter - Outsourced Pharma Edition
LEO Pharma and MorphoSys have formed a strategic partnership to develop peptide-derived therapeutics. LEO Pharma will select lead molecules using...Read More... The post Deals and M&As this week:...
Following execution of MoUs with pharma companies─ Centaur, SG Pharma, Arco Lifesciences, BDH Pharma, Maharashtra Airport Development Company Ltd (MADC) has recently inked MoUs with pharma companies
Zealand Pharma has sold its future royalty streams and potential commercial milestones for Soliqua® 100/33/Suliqua® and Lyxumia®/Adlyxin® to Royalty Pharma...Read More... The post Deals this week:...
China Resources Pharma will pay $667 million to acquire all the outstanding shares of Jiangzhong Pharma, a listed company. Three weeks ago, CR Pharma announced plans to acquire a stake in the parent c...
Fluoride Chewable Tablets 0.5 mg
Fluoride Chewable Tablets 1 mg
Metoprolol Tartrate Tablets, USP
Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )
Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.
Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...
In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...
According to the Treaty on the Eurasian Economic Union, a common pharmaceutical market was supposed to become operational on January 1, 2016. Nevertheless, the responsible parties did not meet the dea...
The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...
To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.
The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...
Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...
The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...
Aptalis Pharma is a privately held, leading specialty pharmaceutical company providing innovative, effective therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorder...
H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...
LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...
Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...
FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...
We have published hundreds of Aptalis Pharma, Inc. news stories on BioPortfolio along with dozens of Aptalis Pharma, Inc. Clinical Trials and PubMed Articles about Aptalis Pharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aptalis Pharma, Inc. Companies in our database. You can also find out about relevant Aptalis Pharma, Inc. Drugs and Medications on this site too.
Affecting over 8,500 people in the UK, Cystic Fibrosis (CF) is one of the UK's most common life-threatening inherited diseases. Around half of the CF population can expect to live over 38 years, although improvements in treatments mean a baby born ...